With the deepening of research, it has been found that SEMA6D is widely upregulated in gastric cancer and esophageal cancer, and participates in the regulation of cancer progression (Cai et al. 2018; Lu et al. 2016; Zhao et al. 2006). The gene discussed is SEMA6D; the disease is cancer.